Topic Review
Biomarkers for Early Detection of Cognitive Impairment
Dementia is a major cause of poor quality of life, disability, and mortality in old age. According to the geroscience paradigm, the mechanisms that drive the aging process are also involved in the pathogenesis of chronic degenerative diseases, including dementia. The dissection of such mechanisms is therefore instrumental in providing biological targets for interventions and new sources for biomarkers. Within the geroscience paradigm, several biomarkers have been discovered that can be measured in blood and allow early identification of individuals at risk of cognitive impairment. Examples of such markers include inflammatory biomolecules, markers of neuroaxonal damage, extracellular vesicles, and DNA methylation. Furthermore, gait speed, measured at usual and fast pace and as dual task, has shown to detect individuals at risk of future dementia.
  • 64
  • 18 Feb 2024
Topic Review
Cognitive Function with Nutritional Supplements in Aging
Cognitive impairment and dementia are burgeoning public health concerns, especially given the increasing longevity of the global population. These conditions not only affect the quality of life of individuals and their families, but also pose significant economic burdens on healthcare systems. 
  • 204
  • 02 Jan 2024
Topic Review
Age-Associated Changes of Sirtuin 2 Expression
Sirtuin 2 (SIRT2), one of the seven members of the sirtuin family, has emerged as a potential regulator of aging and age-related pathologies since several studies have demonstrated that it shows age-related changes in humans and different animal models. A detailed analysis of the relevant works addressing this topic shows that the changes that occur in SIRT2 with aging seem to be opposite in the brain and in the periphery. 
  • 109
  • 15 Dec 2023
Topic Review
Topical Cellular/Tissue and Molecular Aspects in Alzheimer’s Disease
One of the most complex and challenging developments at the beginning of the third millennium is the alarming increase in demographic aging, mainly—but not exclusively—affecting developed countries. This reality results in one of the harsh medical, social, and economic consequences: the continuously increasing number of people with dementia, including Alzheimer’s disease (AD), which accounts for up to 80% of all such types of pathology. Its large and progressive disabling potential, which eventually leads to death, therefore represents an important public health matter, especially because there is no known cure for this disease. Consequently, periodic reappraisals of different therapeutic possibilities are necessary. 
  • 110
  • 12 Dec 2023
Topic Review
XBP1 Modulates the Aging Cardiorenal System
X-box binding protein 1 (XBP1) is a unique basic-region leucine zipper (bZIP) transcription factor. Over recent years, the powerful biological functions of XBP1 in oxidative stress have been gradually revealed. When the redox balance remains undisturbed, oxidative stress plays a role in physiological adaptations and signal transduction. However, during the aging process, increased cellular senescence and reduced levels of endogenous antioxidants cause an oxidative imbalance in the cardiorenal system.
  • 250
  • 15 Nov 2023
Topic Review
Clinical Outcomes in Persons with Dementia
Dementia is an umbrella terms that encapsulated a number of neurodegenerative, irreversibly progressive disorders that are marked by cognitive decline and a steady reduction in everyday function, and it is typically accompanied by behavioral issues. 
  • 156
  • 13 Nov 2023
Topic Review
Medical Challenges of HIV and Ageing Population
The continuing increase in patient numbers and improvement in healthcare provisions of HIV services in the UK, alongside the effectiveness of combined antiretroviral therapy (cART), has resulted in increasing numbers of the ageing population among people living with HIV (PLWH). It is expected that geriatricians will need to deal with many older people living with HIV (OPLWH) as life expectancy increases. Therefore, geriatric syndromes in OPLWH will be similar to the normal population, such as falls, cognitive decline, frailty, dementia, hypertension, diabetes and polypharmacy. The increase in the long-term use of cART, diabetes, dyslipidaemia and hypertension may lead to high prevalence of cardiovascular disease (CVD). The treatment of such conditions may lead to polypharmacy and may increase the risk of cART drug–drug interactions. In addition, the risk of developing infection and cancer is high. OPLWH may develop an early onset of low bone mineral density (BMD), osteoporosis and fractures. 
  • 81
  • 17 Oct 2023
Topic Review
Diet, Nutrition, and Oral Health in Older Adults
Diet, nutrition, and oral health are closely linked. Malnutrition is a challenging health concern in older adults that is associated with physical decline affecting their daily activities and quality of life.
  • 227
  • 07 Oct 2023
Topic Review
Psychedelics for Treating Alzheimer’s Disease and Related Depression
Alzheimer’s disease (AD), the most common form of senile dementia, is poised to place an even greater societal and healthcare burden as the population ages. Psychedelic drugs target AD-related psychological pathology and symptoms such as depression. Using microdosing, psychedelic drugs may prove to help combat this devastating disease by eliciting psychiatric benefits via acting through various mechanisms of action such as serotonin and dopamine pathways.
  • 268
  • 18 Aug 2023
Topic Review
Management of Coronary Artery Disease in Older Adults
Coronary artery disease (CAD) is highly prevalent in older adults, yet its management remains challenging. Treatment choices are made complex by the frailty burden of older patients, a high prevalence of comorbidities and body composition abnormalities (e.g., sarcopenia), the complexity of coronary anatomy, and the frequent presence of multivessel disease, as well as the coexistence of major ischemic and bleeding risk factors.
  • 524
  • 16 Aug 2023
  • Page
  • of
  • 5